These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

531 related items for PubMed ID: 19954246

  • 21. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
    Beaulieu PL, Wernic D, Abraham A, Anderson PC, Bogri T, Bousquet Y, Croteau G, Guse I, Lamarre D, Liard F, Paris W, Thibeault D, Pav S, Tong L.
    J Med Chem; 1997 Jul 04; 40(14):2164-76. PubMed ID: 9216835
    [Abstract] [Full Text] [Related]

  • 22. Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors.
    Adrian Meredith J, Wallberg H, Vrang L, Oscarson S, Parkes K, Hallberg A, Samuelsson B.
    Eur J Med Chem; 2010 Jan 04; 45(1):160-70. PubMed ID: 19926360
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Structure-based design: synthesis and biological evaluation of a series of novel cycloamide-derived HIV-1 protease inhibitors.
    Ghosh AK, Swanson LM, Cho H, Leshchenko S, Hussain KA, Kay S, Walters DE, Koh Y, Mitsuya H.
    J Med Chem; 2005 May 19; 48(10):3576-85. PubMed ID: 15887965
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization.
    Whiting M, Tripp JC, Lin YC, Lindstrom W, Olson AJ, Elder JH, Sharpless KB, Fokin VV.
    J Med Chem; 2006 Dec 28; 49(26):7697-710. PubMed ID: 17181152
    [Abstract] [Full Text] [Related]

  • 29. Design, synthesis, evaluation, and crystallographic-based structural studies of HIV-1 protease inhibitors with reduced response to the V82A mutation.
    Clemente JC, Robbins A, Graña P, Paleo MR, Correa JF, Villaverde MC, Sardina FJ, Govindasamy L, Agbandje-McKenna M, McKenna R, Dunn BM, Sussman F.
    J Med Chem; 2008 Feb 28; 51(4):852-60. PubMed ID: 18215016
    [Abstract] [Full Text] [Related]

  • 30. A novel dipeptide-based HIV protease inhibitor containing allophenylnorstatine.
    Abdel-Rahman HM, el-Koussi NA, Alkaramany GS, Youssef AF, Kiso Y.
    Arch Pharm (Weinheim); 2004 Nov 28; 337(11):587-98. PubMed ID: 15540219
    [Abstract] [Full Text] [Related]

  • 31. Inorganic polyhedral metallacarborane inhibitors of HIV protease: a new approach to overcoming antiviral resistance.
    Kozísek M, Cígler P, Lepsík M, Fanfrlík J, Rezácová P, Brynda J, Pokorná J, Plesek J, Grüner B, Grantz Sasková K, Václavíková J, Král V, Konvalinka J.
    J Med Chem; 2008 Aug 14; 51(15):4839-43. PubMed ID: 18598016
    [Abstract] [Full Text] [Related]

  • 32. Structural analysis of lead fullerene-based inhibitor bound to human immunodeficiency virus type 1 protease in solution from molecular dynamics simulations.
    Lee VS, Nimmanpipug P, Aruksakunwong O, Promsri S, Sompornpisut P, Hannongbua S.
    J Mol Graph Model; 2007 Sep 14; 26(2):558-70. PubMed ID: 17468026
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Aza-peptide analogs as potent human immunodeficiency virus type-1 protease inhibitors with oral bioavailability.
    Fässler A, Bold G, Capraro HG, Cozens R, Mestan J, Poncioni B, Rösel J, Tintelnot-Blomley M, Lang M.
    J Med Chem; 1996 Aug 02; 39(16):3203-16. PubMed ID: 8759643
    [Abstract] [Full Text] [Related]

  • 38. Enamino-oxindole HIV protease inhibitors.
    Eissenstat M, Guerassina T, Gulnik S, Afonina E, Silva AM, Ludtke D, Yokoe H, Yu B, Erickson J.
    Bioorg Med Chem Lett; 2012 Aug 01; 22(15):5078-83. PubMed ID: 22749283
    [Abstract] [Full Text] [Related]

  • 39. Synthesis and biological evaluation of novel amprenavir-based P1-substituted bi-aryl derivatives as ultra-potent HIV-1 protease inhibitors.
    Yan J, Huang N, Li S, Yang LM, Xing W, Zheng YT, Hu Y.
    Bioorg Med Chem Lett; 2012 Mar 01; 22(5):1976-9. PubMed ID: 22306123
    [Abstract] [Full Text] [Related]

  • 40. Design, biologic evaluation, and SAR of novel pseudo-peptide incorporating benzheterocycles as HIV-1 protease inhibitors.
    He M, Zhang H, Yao X, Eckart M, Zuo E, Yang M.
    Chem Biol Drug Des; 2010 Aug 01; 76(2):174-80. PubMed ID: 20572811
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.